CARNA BIOSCIENCES
Live / Registered — Registered — Section 71 accepted (as of 10 Mar 2026)
What this means for you
Registered since 21 Mar 2006. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79008908
- Registration number
- 3071237
- Mark type
- Stylized text
- Filed
- 04 Jan 2005
- Published for opposition
- 27 Dec 2005
- Registered
- 21 Mar 2006
- Attorney of record
- Michael S. Hargis
Goods and services
- Class 001 — Chemicals: Peptide for in vitro research use and for scientific and medical research; polypeptide for in vitro research use and for scientific and medical research; protein for in vitro research use and for scientific and medical research; chemical reagents for non-medical purposes and non-veterinary purposes; and ferments for in vitro research use and for scientific and medical research
- Class 005 — Pharmaceuticals: Chemical reagents for medical or veterinary purposes [; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; diagnostic preparations for medical purposes; drugs for medical purposes for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; medicines for human purposes for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; organotherapy preparations for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; pharmaceutical preparations for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; serotherapeutic medicines for the treatment of cancer, inflammation, dermal diseases, heart diseases, respiratory diseases and disorders, gastrointestinal diseases, infectious diseases, bone diseases, circulatory disease, cerebral diseases and articular rheumatism; pharmaceutical preparations for skin care; biological preparations for medical purposes; and ferments for medical or veterinary use ]
- Class 042 — Scientific and technological services: [ Bacteriological research; ] biological research; [ chemical analysis; chemical research; chemistry services; cosmetic research; mechanical research; calibration measuring; and ] biological or chemical research consultancy
Owner
Prosecution history
- 10 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 10 Mar 2026 — REGISTERED-SEC.71 ACCEPTED
- 09 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Nov 2025 — TEAS SECTION 71 RECEIVED
- 27 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Oct 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 27 Oct 2025 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 27 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 21 Mar 2025 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 10 Oct 2024 — INTERNATIONAL REGISTRATION RENEWED
- 17 Jan 2019 — USPTO CORRECTION PROCESSED BY IB
- 13 Sept 2017 — GENERIC MADRID TRANSACTION SENT TO IB